BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Alkeus Pharmaceuticals Inc.

Headquarters: Boston, MA, United States of America
Year Founded: N/A
Status: Private

BioCentury | Nov 8, 2024
Management Tracks

Moderna expands executive committee, moves commercial under Hoge

Plus: New CFOs at Alkeus, ClaciMedica, and updates from Clairity and Kincell
BioCentury | Jul 16, 2024
Management Tracks

Nadir Mahmood returning to Nkarta

Plus: Perry Sternberg named CEO of Sydnexis, and updates from SFA, Alkeus and Optibrium
BioCentury | Jul 3, 2024
Management Tracks

Dahan succeeds Saad as Alkeus CEO

Plus: Fox becomes interim CEO of Alphina and updates from Inovio and BenevolentAI
BioCentury | Jun 1, 2024
Management Tracks

Verve promotes Lister to CSO

Plus: Quantum-Si appoints Kummeth independent chair and updates from Alkeus and SAB
BioCentury | Jan 25, 2024
Management Tracks

Moeller named CEO of BenevolentAI

Plus: new CFO at Orion and updates from Alkeus and Immorta
BioCentury | Jun 5, 2023
Product Development

Highlights from ASCO: a BioCentury Podcast 

The IRA and cancer drugs, plus readouts from ADCs, BCMA therapies and more
BioCentury | Jun 5, 2023
Product Development

As Vertex founder Boger returns, long-simmering Alkeus draws $150M for Stargardt program

After subsisting for more than a decade on very little cash, tiny biotech believes registrational data point way to building a larger company
BioCentury | Oct 21, 2013
Politics & Policy

FDA awards over $14M in grants for rare diseases

BioCentury | May 28, 2012
Company News

Alkeus board of directors update

BioCentury | May 24, 2012
Company News

Vertex's Boger joins eye company Alkeus

Items per page:
1 - 10 of 10